Proarrhythmic electrical remodelling is associated with increased beat-to-beat variability of repolarisation

Cardiovascular Research

Volumn 73, Issue 3, 2007, Pages 521-530

  Thomsen, Morten B ^a   Oros, Avram ^a   Schoenmakers, Marieke ^a   van Opstal, Jurren M ^a   Maas, Joep N ^a   Beekman, Jet D M ^a   Vos, Marc A ^a  

^a Department of Medical Physiology ^*  (Netherlands)

Author keywords

ECG; Heart rate variability; Remodelling; Repolarisation; Ventricular arrhythmias

Indexed keywords

DOFETILIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CONTROLLED STUDY; DOG; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE PERFORMANCE; HEART MUSCLE POTENTIAL; HEART PROARRHYTHMIA; HEART RATE VARIABILITY; HEART REPOLARIZATION; HEART VENTRICLE REMODELING; MALE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SINUS RHYTHM;

ACTION POTENTIALS; ACUTE DISEASE; ANIMALS; ARRHYTHMIA; DEATH, SUDDEN, CARDIAC; DOGS; ELECTROCARDIOGRAPHY; FEMALE; HEART BLOCK; HEART CONDUCTION SYSTEM; HEART RATE; MALE; PHENETHYLAMINES; POTASSIUM CHANNEL BLOCKERS; SULFONAMIDES; TORSADES DE POINTES; VENTRICULAR REMODELING;

EID: 33846067670     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.11.025     Document Type: Article

References (32)

1. Dessertenne F. La tachycardie ventriculaire à deux foyers opposés variables. Arch des Mal du Cœur 59 (1966) 263-272
2. Roden D.M. Taking the "idio" out of "idiosyncratic": predicting torsades de pointes. Pacing Clin Electrophysiol 21 (1998) 1029-1034
3. Thomsen M.B., Matz J., Volders P.G., and Vos M.A. Assessing the proarrhythmic potential of drugs: current status of models and surrogate parameters of torsades de pointes arrhythmias. Pharmacol Ther 112 (2006) 150-170
4. Kaab S., Hinterseer M., Nabauer M., and Steinbeck G. Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome - a case-control pilot study using i.v. sotalol. Eur Heart J 24 (2003) 649-657
5. Thomsen M.B., Verduyn S.C., Stengl M., Beekman J.D., de Pater G., Van Opstal J.M., et al. Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs. Circulation 110 (2004) 2453-2459
6. Antzelevitch C., Sun Z.Q., Zhang Z.Q., and Yan G.X. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes. J Am Coll Cardiol 28 (1996) 1836-1848
7. Hondeghem L.M., Carlsson L., and Duker G. Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic. Circulation 103 (2001) 2004-2013
8. Gbadebo T.D., Trimble R.W., Khoo M.S., Temple J., Roden D.M., and Anderson M.E. Calmodulin inhibitor W-7 unmasks a novel electrocardiographic parameter that predicts initiation of torsade de pointes. Circulation 105 (2002) 770-774
9. Thomsen M.B., Volders P.G., Stengl M., Spätjens R.L., Beekman J.D., Bischoff U., et al. Electrophysiological safety of sertindole in dogs with normal and remodeled hearts. J Pharmacol Exp Ther 307 (2003) 776-784
10. van Opstal J.M., Leunissen J.D., Wellens H.J., and Vos M.A. Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of torsade de pointes arrhythmias. Eur J Pharmacol 412 (2001) 67-76
11. Sipido K.R., Volders P.G., de Groot S.H., Verdonck F., Van de Werf F., Wellens H.J., et al. Enhanced Ca(2+) release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: potential link between contractile adaptation and arrhythmogenesis. Circulation 102 (2000) 2137-2144
12. Volders P.G., Sipido K.R., Vos M.A., Kulcsar A., Verduyn S.C., and Wellens H.J. Cellular basis of biventricular hypertrophy and arrhythmogenesis in dogs with chronic complete atrioventricular block and acquired torsade de pointes. Circulation 98 (1998) 1136-1147
13. Thomsen M.B., Truin M., van Opstal J.M., Beekman J.D., Volders P.G., Stengl M., et al. Sudden cardiac death in dogs with remodeled hearts is associated with larger beat-to-beat variability of repolarization. Basic Res Cardiol 100 (2005) 279-287
14. Schoenmakers M., Ramakers C., van Opstal J.M., Leunissen J.D., Londono C., and Vos M.A. Asynchronous development of electrical remodeling and cardiac hypertrophy in the complete AV block dog. Cardiovasc Res 59 (2003) 351-359
15. Van de Water A., Verheyen J., Xhonneux R., and Reneman R.S. An improved method to correct the QT interval of the electrocardiogram for changes in heart rate. J Pharmacol Methods 22 (1989) 207-217
16. Vos M.A., de Groot S.H., Verduyn S.C., van der Zande J., Leunissen H.D., Cleutjens J.P., et al. Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling. Circulation 98 (1998) 1125-1135
17. Donker D.W., Volders P.G., Arts T., Bekkers B.C., Hofstra L., Spatjens R.L., et al. End-diastolic myofiber stress and ejection strain increase with ventricular volume overload - serial in-vivo analyses in dogs with complete atrioventricular block. Basic Res Cardiol 100 (2005) 372-382
18. de Groot S.H., Schoenmakers M., Molenschot M.M., Leunissen J.D., Wellens H.J., and Vos M.A. Contractile adaptations preserving cardiac output predispose the hypertrophied canine heart to delayed afterdepolarization-dependent ventricular arrhythmias. Circulation 102 (2000) 2145-2151
19. Volders P.G., Sipido K.R., Vos M.A., Spatjens R.L., Leunissen J.D., Carmeliet E., et al. Downregulation of delayed rectifier K(+) currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes. Circulation 100 (1999) 2455-2461
20. Thomsen M.B., Volders P.G., Beekman J.D., Matz J., and Vos M.A. Beat-to-beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes. J Am Coll Cardiol 48 (2006) 1768-1776
21. Wu L., Shryock J.C., Song Y., and Belardinelli L. An increase in late sodium current potentiates the proarrhythmic activities of low-risk QT - prolonging drugs in female rabbit hearts. J Pharmacol Exp Ther 316 (2006) 718-726
22. Torp-Pedersen C., Moller M., Bloch-Thomsen P.E., Kober L., Sandoe E., Egstrup K., et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med 341 (1999) 857-865
23. Roden D.M. Drug-induced prolongation of the QT interval. N Engl J Med 350 (2004) 1013-1022
24. Janse M.J., van der Steen A.B., and van Dam R.T. Refractory period of the dog's ventricular myocardium following sudden changes in frequency. Circ Res 24 (1969) 251-262
25. Franz M.R., Swerdlow C.D., Liem L.B., and Schaefer J. Cycle length dependence of human action potential duration in vivo. Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies. J Clin Invest 82 (1988) 972-979
26. Schneider J., Hauser R., Andreas J.O., Linz K., and Jahnel U. Differential effects of human ether-a-go-go-related gene (HERG) blocking agents on QT duration variability in conscious dogs. Eur J Pharmacol 512 (2005) 53-60
27. Ettinger S.J., and Suter P.F. Canine cardiology (1970), W. B. Saunders Company, London 272
28. Stengl M., Ramakers C., Donker D.W., Nabar A., Rybin A.V., Spatjens R.L., et al. Temporal patterns of electrical remodeling in canine ventricular hypertrophy: focus on IKs downregulation and blunted beta-adrenergic activation. Cardiovasc Res 72 (2006) 90-100
29. Kozhevnikov D.O., Yamamoto K., Robotis D., Restivo M., and El Sherif N. Electrophysiological mechanism of enhanced susceptibility of hypertrophied heart to acquired torsade de pointes arrhythmias: tridimensional mapping of activation and recovery patterns. Circulation 105 (2002) 1128-1134
30. Verduyn S.C., Vos M.A., van der Zande J., van der Hulst F.F., and Wellens H.J. Role of interventricular dispersion of repolarization in acquired torsade-de-pointes arrhythmias: reversal by magnesium. Cardiovasc Res 34 (1997) 453-463
31. Haverkamp W., Breithardt G., Camm A.J., Janse M.J., Rosen M.R., Antzelevitch C., et al. The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. Cardiovasc Res 47 (2000) 219-233
32. Hinterseer M., Beckmann B.M., Thomsen M.B., Pfeufer A., Perz S., Wichmann H.E., et al. Beat-to-beat variability of QT intervals is increased in drug-induced and congenital long-QT syndromes. Heart Rhythm 3 (2006) S269-S270